A four-month-old infant, thought to suffer from cerebral palsy, presented with respiratory failure on the background of a gradually deteriorating general level of function. Whilst being ventilated in intensive care he was noted to have severe muscle weakness. A disorder of the neuromuscular junction was suspected and he was subsequently demonstrated to have a congenital myasthenic syndrome. Anticholinesterase therapy produced a dramatic recovery. The congenital myasthenic syndromes and the diagnosis of a "floppy baby" are briefly reviewed.
The hypotonic infant presents both diagnostic and management problems. Defective neuromuscular transmission is an unusual cause of such hypotonia. The congenital myasthenic syndromes are a rare and heterogenous group of disorders, about which our genetic understanding is still evolving. They are distinct from adult myasthenia gravis, involving inherited rather than autoimmune defects of the neuromuscular junction. The various conditions may involve disorders of presynaptic, synaptic or postsynaptic function. The potential for an excellent response to anticholinesterase therapy, as in the case we present, underlines the importance of making the diagnosis of congenital myasthenic syndrome. We review the diagnostic process in such infants and the current understanding of the congenital myasthenic syndromes.
CASE REPORT
A four-month-old male, previously diagnosed with cerebral palsy from birth hypoxia, presented to the emergency department with severe respiratory distress. This had been worsening for two to three days prior to admission.
After an uneventful pregnancy, the infant had been delivered at term by urgent caesarean section because of foetal distress. He required resuscitation and respiratory support for meconium inhalation. During the neonatal period, poor feeding, weak cry and a lack of facial movement were noted. Neurological examination revealed mild left-sided weakness and normal reflexes. He was discharged on day 18 with a diagnosis of "meconium aspiration and probable birth asphyxia". He was readmitted at six weeks of age with feeding difficulties and respiratory distress. At that time he had generalized hypotonia and bulbar incoordination. The respiratory distress was attributed to aspiration. Nasogastric feeds were commenced and he required a support harness for his unstable hips. At discharge one month later he still had intermittent respiratory distress. When reviewed at 14 weeks, still on nasogastric feeds, he was noted to "struggle to breathe and manage secretions". Plans were made for a feeding gastrostomy and sleep studies.
On examination the infant was pale, diaphoretic, tachypnoeic (50/min) and tachycardic (200/min). He was drowsy and moved his limbs weakly. Reflexes were noted to be present but difficult to elicit. He was admitted to the intensive care unit where ventilatory function deteriorated rapidly (P a O 2 : 34 mmHg, P a CO 2 : 118 mmHg) and he required intubation and ventilation. Intubation was facilitated with thiopentone 5 mg/kg and vecuronium 0.1mg/kg. Copious secretions were suctioned from the airways. Chest X-ray showed right upper lobe collapse. Aspiration, with or without sepsis, was felt to be the likely cause of the respiratory failure. Antibiotics, including gentamicin, and chest physiotherapy were commenced. Extubation was attempted after 24 hours but was unsuccessful due to inadequate respiratory effort. He was noted to be inactive and floppy during this time. Thick sputum plugs were suctioned from the airway after physiotherapy. Thyroid function tests, echocardiography, brainstem evoked potentials and magnetic resonance imaging of the brainstem were all normal. Extubation failed again on day 3 for the same reasons. A muscle biopsy was planned to exclude muscular dystrophy and the family were advised of a likely poor prognosis.
On day 4, one of the intensive care staff noted that the patient had an appearance consistent with that of neuromuscular blockade. The hypotonia appeared to be generalized with inadequate respiratory effort and inability to open the eyes. Since a number of doses of vecuronium had been administered and failure of the neuromuscular junction had not been considered as a cause of the infant's weakness, a decision was made to give a test dose of neostigmine intravenously. This produced a dramatic improvement in muscle tone and ventilatory effort.
Further doses of neostigmine (2.5 mg of the intravenous solution given via the nasogastric tube) reliably improved muscle tone and respiratory function. The physiotherapist documented a stronger cough and the orthopaedic team noted that the hips were now stable and the support harness no longer needed. The effect of the neostigmine lasted only four to six hours, although no further muscle relaxant had been administered.
Electromyographic studies were performed on day 6 and showed neostigmine-reversed fatiguability consistent with a neuromuscular junction disorder. A diagnosis of congenital myasthenic syndrome was made.
Medication was changed from neostigmine to pyridostigmine (2 mg/kg every six hours orally). Significant clinical deterioration continued to occur 83 
Anaesthesia and Intensive Care, Vol. 28, No. 1, February 2000 FIGURE 1: Electromyography recordings from this patient. "A" represents muscle response to stimulus before neostigmine and "B" represents the response six minutes after dose of neostigmine given. Stimulus was made at the ulnar nerve at 25 mA and 2 Hz. Note the scale on "B" is doubled to 2 mV, on the same scale the response would be double the size. The report: ">50% CMAP decrement . . . reduced by IV neostigmine, partially at one minute, completely at six minutes. These results indicate a neuromuscular junction abnormality. They are consistent with congenital myasthenia." toward the end of each six hour period. Atropine was given to control bronchorrhea and bradycardia. He was extubated successfully on day eight, discharged from intensive care on day nine and then from hospital on day 11.
Review two months later (age six months), found him without further respiratory problems and able to roll prone to supine and supine to prone. Feeding was still via the nasogastric tube. Three months after discharge he was tolerating oral thickened fluids and starting to crawl. The nasogastric tube was removed. Walking occurred at 14 months and by 18 months he was able to climb stairs. At age 2 1 ¼2 yrs he is active, runs, dresses himself, is able to eat solids with a fork and spoon and is toilet trained. There is no sign of cognitive impairment. He remains on oral pyridostigmine 30 mg tds.
There was no family history of myasthenia, nor did the mother have evidence of subclinical myasthenia gravis. Acetylcholine (ACh)-receptor antibodies were negative. The parents declined the offer of muscle biopsy which may have helped further identify the specific myasthenic syndrome.
DISCUSSION
Infant myasthenia, first described in 1877 1 , had been assumed to be a variant of the adult condition until its familial nature was noted in 1949 2 . There was further evidence of a distinct aetiology when the absence of ACh-receptor antibodies was reported in 1979 3 . It has since become apparent that infant myasthenia is caused by a heterogeneous group of disorders including the congenital myasthenic syndromes. These are rare, with a reported incidence of less than one per 500,000 live births 1 . Transmission may be autosomal dominant or recessive and affected infants are usually hypotonic from birth.
The diagnostic approach to the hypotonic infant involves history, physical examination and selected investigations. Family history of congenital syndromes and muscular abnormalities is important, as are the pregnancy and birth details. The rate of progression of symptoms will help distinguish between fixed birth lesions (static, no progression); degenerative disorders (slow progress); and infectious or toxic disorders (rapid progress). Physical examination aims to confirm the presence of hypotonia, distinguish it from simple weakness or fatiguability, and then characterize it as local or global. Localized hypotonia should prompt a search for local nerve injury (e.g., brachial plexus birth trauma). If hypotonia is global, then upper and lower motor neurone dysfunction must be differentiated. In adults, an upper motor neurone lesion will generally result in hypertonia but this may not be so in infants 4 . Tendon reflexes may be similarly unhelpful. Normal mentation and behaviour would point toward a lower motor neurone cause. Ventilatory failure in infants, even hypotonic infants, is rare and, in the absence of a treatable cause, has a poor prognosis.
Investigations may include magnetic resonance imaging of brain and spinal cord, looking for tumour, infection, structural abnormalities or demyelination. If there are features of lower motor unit dysfunction, then muscle biopsy, nerve conduction testing and electromyography may be appropriate. Electromyography is not always advocated as a baseline study because of its poor sensitivity 5 . Muscle biopsy is most likely to be diagnostic.
The list of differential diagnoses for the "floppy baby" is long 6-10 and failure of the neuromuscular junction rare. Lesions anywhere along the motor pathway from the cerebral cortex to the muscle itself can result in hypotonia. The upper or lower motor neurone may be affected. About 75% of infant hypotonia is due to cerebral dysfunction caused by birth hypoxia, trauma or congenital syndromes (such as trisomy 21). Affected infants will often display other central deficits such as behavioural disturbances and later may develop spasticity. Cervical spine birth trauma may also cause an upper motor neurone lesion. The commonest lower motor unit problem is inherited spinal muscular atrophy, also known as Werdnig-Hoffman disease. This results from degeneration of the anterior horn cell and carries a dismal prognosis. The motor nerve itself may be damaged as a result of congenital, metabolic or inflammatory neuropathies. Guillain-Barré syndrome, whilst uncommon in this age group, has been described in infants as young as three weeks old 11 . The muscle itself may be weakened by the muscular and myotonic dystrophies, metabolic disorders and conditions such as central core disease and nemaline myopathy. In a small group of "floppy babies" (5%), hypotonia is caused by systemic disorders such as sepsis, hypothyroidism and viral infection.
If the neuromuscular junction has been identified as the site of disturbance in a floppy infant there are four main diagnostic possibilities.
(1) Autoimmune myasthenia gravis: more commonly seen in adults, may have a juvenile onset as early as six months. ACh-receptor antibodies are present. (2) Transient neonatal myasthenia: a self-limiting disorder, which results from placental transfer of ACh-receptor antibodies from a myasthenic mother to her newborn. This occurs in about 8% of such births 12 , and the hypotonia may last from days to weeks. (3) Infantile botulism: results from intestinal colonization with Clostridium botulinum. Exotoxin from the spores irreversibly binds to cholinergic receptors in the neuromuscular junction. Sudden death may occur and there is no response to anticholinesterase medication. Electromyography will show decreased action potential amplitude and post-tetanic facilitation 13 . This disorder is self-limiting if appropriate supportive care is provided. (4) Congenital myasthenic syndromes: a rare group of disorders which arise from inherited structural or functional abnormalities of the neuromuscular junction. Diagnosis of congenital myasthenic syndrome is based on clinical and electrophysiological findings. Specific syndromes can be differentiated by electron microscopic and immunochemical studies of a muscle biopsy specimen 14 . Much recent progress has been made in the identification of the specific genetic defects responsible.
Classification based on the anatomic site of the defect divides the conditions into presynaptic, synaptic or postsynaptic syndromes 15 . Alternate classifications have been proposed by Janas 5 and the European Neuromuscular Council 16 . The commonest presynaptic syndrome, known as "familial infantile myasthenia", is associated with synaptic vesicles of reduced size and a defect in chromosome 17p 17 . It is characterized by episodic respiratory and bulbar weakness and sometimes sudden death 18 . Synaptic function itself is disturbed in "acetylcholinesterase deficiency", for which no specific genetic defect has been identified. The postsynaptic disorders involve deficiency or dysfunction of the acetylcholine receptor. It is in the genetic understanding of this group that most recent progress has been made. Fifty-six specific mutations of the genes coding for the ACh-Receptor have been identified since 1994, most involving the epsilon subunit 19 (Engel 1998, unpublished) . The postsynaptic syndromes identified are: "ACh-Receptor deficiency", "slow channel syndrome" 20 and "high conductance fast channel syndrome" 21 . These latter two involve alterations in the rate of conduction through the ACh-Receptor channel. Mode of transmission and response to treatment varies between syndromes. For example, acetylcholinesterase inhibitors will improve muscle tone in "familial infantile myasthenia" but worsen it in "slow channel syndrome" (Table 1. ).
Therapy depends on correct identification of the syndrome. Our patient's clinical course and good response to neostigmine would suggest the "familial infantile" or possibly "acetylcholinereceptor deficiency" syndrome as the cause. We found very little information in the literature to help with anticholinesterase dosages, and arrived at our prescribed doses by consultation with pharmacy and trial and error. We encountered problems with bradycardia and bronchorrhoea, which were only partly controlled with atropine. The other mainstays of treatment were regular chest physiotherapy and supportive nutritional and respiratory care. Therapies demonstrated to be of some benefit in the literature include ephedrine 22 , quinine 14 and 3,4 diaminopyridine 23, 24 .
Affected children may present for anaesthesia for muscle biopsy, feeding gastrostomies or orthopaedic stabilization procedures. There are no published guidelines for the anaesthetic management of these patients, so it must be extrapolated from experience with adult myasthenics. The use of isoflurane for intensive care sedation in such a child has recently been described, avoiding the use of neuromuscular blockers 25 .
Baraka, in his review of the anaesthetic management of adult myasthenia gravis, accepts the use of monitored and titrated neuromuscular blockade as safe 26 . It is probable that the use of vecuronium and aminoglycosides in our patient contributed to the prolonged weakness. Slow progress with anticholinesterase severe involvement of may make worse. scapula and forearm.
Fast Channel
Onset neonatal Some improvement Syndrome (AR) with anticholinesterase Though rare, the congenital myasthenic syndromes are important because diagnosis and treatment may have a major impact on outcome. Subclinical cases may be unmasked during the perioperative period by drugs or physiological stressors. Assessment of the neuromuscular junction needs to be considered in any infant with ventilatory failure.
